July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Pyruvate protects retinal neurones in culture from nutrient deprivation, excitotoxicity and oxidative stress
Author Affiliations & Notes
  • John Peter Wood
    Ophthalmology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
    Ophthalmology, University of Adelaide, Adelaide, South Australia, Australia
  • Glyn Chidlow
    Ophthalmology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
    Ophthalmology, University of Adelaide, Adelaide, South Australia, Australia
  • Chelsea Guymer
    Ophthalmology, University of Adelaide, Adelaide, South Australia, Australia
  • Teresa Mammone
    Ophthalmology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
    Ophthalmology, University of Adelaide, Adelaide, South Australia, Australia
  • Robert J Casson
    Ophthalmology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
    Ophthalmology, University of Adelaide, Adelaide, South Australia, Australia
  • Footnotes
    Commercial Relationships   John Wood, None; Glyn Chidlow, None; Chelsea Guymer, None; Teresa Mammone, None; Robert Casson, None
  • Footnotes
    Support  National Health and Medical Research Council of Australia (APP1102568)
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 2513. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      John Peter Wood, Glyn Chidlow, Chelsea Guymer, Teresa Mammone, Robert J Casson; Pyruvate protects retinal neurones in culture from nutrient deprivation, excitotoxicity and oxidative stress
      . Invest. Ophthalmol. Vis. Sci. 2018;59(9):2513.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The prominent cellular metabolite, pyruvate, has been shown to possess properties which likely endow it with the potential to protect neurons from insults relating to neurodegenerative disease. In order to address this more closely in the context of the retina, we examined whether this compound was able to protect cultured retinal neurons from nutrient deprivation (ND), excitotoxic challenge (EC) or oxidative stress (OxS): all insults which relate to glaucoma.

Methods : Mixed retinal neuron and glial cultures were prepared from 2 day old rat pups via mechanical and enzymatic digestion. After 7 days, cells were treated for 24 hours with medium lacking glucose and amino acids for ND, 200 µM N-methyl-D-aspartate plus 10mM CaCl2 for EC or 100µM t-butyl hydroperoxide for OxS. Viability of neurons was assessed by immunocytochemistry (β-tubulin, calretinin, GABA), Western immunoblot and MTT assay. Mechanisms of potential neuroprotection were assessed by assays for reactive oxygen species and ATP levels.

Results : ND, EC and OxS reduced neuronal viability in cultures by 93.3%, 48.9% and 89.8% respectively. Different classes of neuron generally responded to similar degrees, except that calretinin-immunoreactive (IR) neurons, which comprised a population of small amacrine cells and large ganglion cells (GCs), were relatively more sensitive to EC than were GABA-IR or β-tubulin-IR neurons. Pyruvate (1mM) was able to reduce neuron death induced by ND and OxS by 85.3% and 78.9% respectively, but was less efficacious in counteracting EC, reducing this only by 45.7%. Notably, in the latter case, pyruvate was particularly able to counteract death of the large calretinin-IR GCs. The effects of pyruvate, which included elevation of cellular ATP and quenching of intracellular reactive oxygen species, were almost entirely counteracted by monocarboxylate transport inhibition.

Conclusions : Pyruvate is able to significantly protect retinal neurons in culture from a panoply of insults. The diverse nature of these insults indicates the potential usefulness of this compound in preserving retinal neurons in diseases such as glaucoma.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×